Clinical trial

Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for…

NCT00255970 · RTI Surgical, Industry · Completed

Key facts

NCT number NCT00255970
Title Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects
Official title Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil
Lead sponsor RTI Surgical, Industry
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Periodontal Diseases
Intervention type Device, Other
Interventions DFDBA, Regenafil
Enrollment 40
Start date Jan 1, 2006
Primary completion Nov 1, 2007
Completion Nov 1, 2007
First posted Nov 21, 2005
Last update posted Aug 10, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies